Suppr超能文献

阿托伐他汀:多发性硬化症。

Atorvastatin: multiple sclerosis.

作者信息

Generali Joyce A, Cada Dennis J

机构信息

Editor-in-Chief, Hospital Pharmacy , and Clinical Professor, Emeritus, Department of Pharmacy Practice, University of Kansas, School of Pharmacy , Kansas City/Lawrence, Kansas , e-mail:

Founder and Contributing Editor, The Formulary , and Editor, Off-Label Drug Facts , e-mail:

出版信息

Hosp Pharm. 2014 Nov;49(10):920-2. doi: 10.1310/hpj4910-920.

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

摘要

本医院药学特色内容摘自《药品未获批用法事实》,这是威科医疗出版的一份刊物。《药品未获批用法事实》是一份面向从业者的资源,提供有关美国食品药品监督管理局未批准的特定药物用法的信息。这本新的文献指南使医疗保健专业人员或临床医生能够快速识别关于未获批用法的已发表研究,并确定在患者护理场景中特定用法是否合理。参考文献引导读者查阅完整文献以获取更全面的信息,然后再做出患者护理决策。有关药品未获批用法的问题或意见,请发送至jgeneral@ku.edu

相似文献

1
Atorvastatin: multiple sclerosis.
Hosp Pharm. 2014 Nov;49(10):920-2. doi: 10.1310/hpj4910-920.
2
Simvastatin: Multiple Sclerosis.
Hosp Pharm. 2015 Jun;50(6):464-6. doi: 10.1310/hpj5006-464.
3
Amantadine: multiple sclerosis-related fatigue.
Hosp Pharm. 2014 Sep;49(8):710-2. doi: 10.1310/hpj4908-710.
4
Sodium Thiosulfate: Calciphylaxis.
Hosp Pharm. 2015 Nov;50(11):975-7. doi: 10.1310/hpj5011-975. Epub 2015 Nov 24.
5
Trazodone: Insomnia (Adults).
Hosp Pharm. 2015 May;50(5):367-9. doi: 10.1310/hpj5005-367.
6
Ciprofloxacin: Tularemia (Adults).
Hosp Pharm. 2015 Apr;50(4):274-6. doi: 10.1310/hpj5004-274. Epub 2015 Apr 8.
7
Montelukast: Chronic Urticaria.
Hosp Pharm. 2015 Jul;50(7):583-5. doi: 10.1310/hpj5007-583. Epub 2015 Jul 31.
8
Pyridostigmine: Postpoliomyelitis Syndrome.
Hosp Pharm. 2016 May;51(5):367-9. doi: 10.1310/hpj5105-367.
9
Montelukast: Eosinophilic Esophagitis.
Hosp Pharm. 2016 Jun;51(6):450-1. doi: 10.1310/hpj5106-450.
10
Rifaximin: irritable bowel syndrome.
Hosp Pharm. 2014 Dec;49(11):1014-6. doi: 10.1310/hpj4911-1014.

本文引用的文献

1
Efficacy of statins in combination with interferon therapy in multiple sclerosis: a meta-analysis.
Am J Health Syst Pharm. 2012 Sep 1;69(17):1494-9. doi: 10.2146/ajhp110675.
2
Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial.
J Neurol. 2012 Nov;259(11):2401-13. doi: 10.1007/s00415-012-6513-7. Epub 2012 May 9.
3
Statins for multiple sclerosis.
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD008386. doi: 10.1002/14651858.CD008386.pub3.
5
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
Neurology. 2008 Oct 28;71(18):1390-5. doi: 10.1212/01.wnl.0000319698.40024.1c. Epub 2008 Jun 4.
6
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis.
PLoS One. 2008 Apr 9;3(4):e1928. doi: 10.1371/journal.pone.0001928.
8
Statins as potential therapeutic agents in neuroinflammatory disorders.
Curr Opin Neurol. 2003 Jun;16(3):393-401. doi: 10.1097/01.wco.0000073942.19076.d1.
9
Statins as immunomodulators: comparison with interferon-beta 1b in MS.
Neurology. 2002 Oct 8;59(7):990-7. doi: 10.1212/wnl.59.7.990.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验